Money Concepts Capital Corp Increases Position in UnitedHealth Group Incorporated (NYSE:UNH)

Money Concepts Capital Corp boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 36.8% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 5,200 shares of the healthcare conglomerate's stock after purchasing an additional 1,400 shares during the quarter. Money Concepts Capital Corp's holdings in UnitedHealth Group were worth $2,723,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in UNH. Geode Capital Management LLC lifted its stake in shares of UnitedHealth Group by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock worth $10,068,869,000 after purchasing an additional 319,515 shares in the last quarter. Capital International Investors boosted its holdings in UnitedHealth Group by 6.2% in the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock worth $7,899,905,000 after acquiring an additional 906,365 shares during the period. Norges Bank purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $6,375,744,000. Northern Trust Corp increased its stake in UnitedHealth Group by 12.5% during the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock worth $4,807,527,000 after buying an additional 1,058,488 shares during the period. Finally, Franklin Resources Inc. grew its stake in shares of UnitedHealth Group by 10.7% during the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock valued at $4,514,178,000 after acquiring an additional 861,854 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms have commented on UNH. Truist Financial reiterated a "buy" rating and set a $360.00 price objective (down from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Oppenheimer dropped their price target on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a research report on Wednesday, May 14th. Barclays dropped their target price on shares of UnitedHealth Group to $350.00 and set an "overweight" rating on the stock in a report on Monday, June 2nd. Piper Sandler lowered their price objective on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a research report on Tuesday, June 3rd. Finally, Erste Group Bank lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $415.57.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the transaction, the director now directly owns 6,033 shares of the company's stock, valued at $1,935,386.40. This represents a 34.07% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO John F. Rex acquired 17,175 shares of the stock in a transaction on Friday, May 16th. The shares were purchased at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the transaction, the chief financial officer now owns 203,796 shares of the company's stock, valued at approximately $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have acquired 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Up 0.1%

Shares of NYSE UNH opened at $302.43 on Friday. The firm has a 50 day moving average price of $339.15 and a 200 day moving average price of $456.28. The stock has a market cap of $274.35 billion, a P/E ratio of 12.66, a P/E/G ratio of 1.43 and a beta of 0.44. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the previous year, the firm posted $6.91 earnings per share. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a $2.21 dividend. The ex-dividend date of this dividend was Monday, June 16th. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.92%. UnitedHealth Group's dividend payout ratio (DPR) is 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.